Summary:
- The article discusses the development of a new oral COVID-19 vaccine candidate by Bharat Biotech, an Indian pharmaceutical company.
- The vaccine, known as BBV154, is a novel intranasal vaccine that is being developed as a potential alternative to injectable COVID-19 vaccines.
- The article highlights the advantages of the intranasal vaccine, including its ability to induce a robust immune response and its potential to provide better protection against COVID-19 variants.